Mark Rygiel is a director in Sterne Kessler’s Mechanical and Design Practice Group with over two decades of experience helping medical device and consumer product companies develop and execute intellectual property (IP) strategies aligned with core business objectives. Recognized by Legal 500 as a “Highly Recommended Lawyer” for patent prosecution and post-grant proceedings, Mark is known for delivering practical, results-driven patent counsel to sophisticated clients managing complex innovation pipelines.

Mark focuses on building, managing, and optimizing large, global patent portfolios for industry-leading companies, particularly in the medical devices and consumer products industries. He works closely with business and R&D leaders to align patent strategy with product development, competitive positioning, and long-term market goals. A key aspect of his practice is analyzing competitor technologies and commercial products to identify risks, uncover strategic opportunities, and guide targeted patent portfolio development. He is particularly experienced in actively mining portfolios to strengthen coverage around high-value products and to enable effective enforcement, licensing, and competitive leverage.

In addition to patent prosecution, Mark has extensive experience in post-grant proceedings before the U.S. Patent and Trademark Office (USPTO) and patent offices outside the U.S., including inter partes review (IPR) proceedings at the Patent Trial and Appeal Board (PTAB) and reexamination. He has served as lead and second chair counsel in numerous high-stakes matters, helping clients protect key patent assets and mitigate competitor threats. His practice also includes freedom-to-operate (FTO) and patent validity analyses, strategic IP due diligence for transactions, and the negotiation of complex settlements and patent licensing arrangements in competitive markets.

Mark is a frequent speaker on advanced patent portfolio management strategies.

Prior to entering law, Mark worked as a business and information technology consultant, designing manufacturing process systems for industrial clients, and gained early engineering experience in the medical device sector at a global respiratory device company. This combination of technical and business experience informs his practical, commercially focused approach to patent and intellectual property strategy.

  • Currently managing prosecution of a global patent portfolio for a $7B+ multinational medical device company focused on wearable monitors and related technologies. The portfolio is strategically developed to align with key commercial products and evolving competitive dynamics, including targeted claim development informed by ongoing analysis of competitor systems. Resulting patent assets have contributed to the company’s strong market position and have been leveraged in patentability challenges and competitive enforcement in the United States and Europe.
  • Led a multi-patent enforcement and licensing campaign for a leading global consumer products manufacturer, resulting in significant licensing fees and competitive advantages for the client. The effort involved strategic assertion of a diverse portfolio against multiple competitors, coordinated negotiations, and development of tailored licensing frameworks. The campaign strengthened the client’s market position while establishing an ongoing revenue stream tied to its core product innovations.
  • Has served as lead patent counsel for more than 20 years to a premier global footwear and apparel company, overseeing worldwide patent portfolio development and providing strategic IP counseling across a broad range of product categories. The portfolio is structured to protect commercially significant innovations, support competitive differentiation, and advance the company’s long-term innovation and market leadership objectives.
  • Successfully defended five U.S. patents for a major global paper-based consumer goods and personal care corporation as lead counsel at the USPTO Patent Trial and Appeal Board (PTAB) against inter partes review (IPR) petitions filed by a direct competitor. The patents protected multiple successful commercial products for the company.
  • Manages patent strategy and worldwide patent filings for a surgical medical device startup, helping build and protect a portfolio aligned with the company’s core technologies and business goals. The representation includes ongoing counseling on intellectual property issues arising from product development, commercialization, and competitive market dynamics.

  • The Legal 500, “Highly Recommended Lawyer – Patent Prosecution (including reexamination and post-grant proceedings)” (2017)

  • J.D., The George Washington University Law School
  • B.S., Mechanical Engineering, University of Notre Dame

  • District of Columbia
  • Pennsylvania
  • United States Patent & Trademark Office

Related News & Insights

From Mark W. Rygiel

Articles

February 24, 2026

Overcoming § 101 in Medical Device Applications

Sterne, Kessler, Goldstein & Fox Tyler Tassone, Mark W. Rygiel

Firm News

August 20, 2024

Treading New Ground: Sterne Kessler Secures First Denial of a Design Patent IPR Petition Since LKQ v. GM

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

June 16, 2023

The Super Eight: These Companies Have Been a Top Workplace Every Year Since 2013

The Washington Post Multiple Authors

Client Alert

July 7, 2020

IP Hot Topic: Patent Prosecution Tool Kit

Carla Ji-Eun Kim

Reports

July 7, 2020

2020 Patent Prosecution Tool Kit

Sterne, Kessler, Goldstein & Fox Multiple Authors

Articles

July 7, 2020

Medical Device Considerations

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

October 28, 2019

Curver Luxembourg v. Home Expressions: Words Can Matter in a Design Patent

Sterne, Kessler, Goldstein & Fox Daniel A. Gajewski

Articles

September 11, 2019

Amazon Seeks to Strike Balance Between Patent Owners and Merchants

Sterne, Kessler, Goldstein & Fox P.L.L.C. Jason A. Fitzsimmons

Articles

September 11, 2019

Design Patent PTO Litigation Statistics (through July 2019)

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Articles

July 31, 2018

Clearing up Conjunctive Claim Construction: PTAB Guidance on the Use of “At Least One Of”

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

July 31, 2018

The Hague System for the Registration of International Design Welcomes Canada

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel, Tracy-Gene G. Durkin

Publication

July 31, 2018

Design Patent PTO Litigation Statistics (Through July 19, 2018)

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

April 25, 2018

Nordt: Structural Limitations Masquerading As Process Limitations

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

April 25, 2018

Read the Fine Print When Using Product Literature for Marking

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

April 25, 2018

Design Patent PTO Litigation Statistics (Through April 16, 2018)

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

January 31, 2018

Arctic Cat: A Chilly Reminder Regarding Licensee Marking

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

January 31, 2018

Patent Marking Basics

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

January 31, 2018

Design Patent PTO Litigation Statistics (Through January 15, 2018)

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

October 25, 2017

“Retro” Designs: Using Your Utility Portfolio to Expand Design Protection

Sterne, Kessler, Goldstein & Fox Daniel A. Gajewski, Mark W. Rygiel

Articles

October 25, 2017

The Goods – News & Notes

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

October 25, 2017

Design Patent PTO Litigation Statistics (Through October 15, 2017)

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

October 24, 2017

Preparing European Priority Applications for Stronger U.S. Patents

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Articles

September 12, 2017

PTAB At 5: Part 2 — Patents That Survive PTAB Scrutiny

Law360 Multiple Authors

Articles

July 31, 2017

3 Tips For Thinking Like An Examiner To Maximize Your Consumer Products Patent’s Shelf Life

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel, Chase Hammond

Articles

July 31, 2017

Brewers & Blades: Avoiding Exhaustion in Products with Consumable Parts

Sterne, Kessler, Goldstein & Fox Daniel A. Gajewski, Mark W. Rygiel

Articles

July 31, 2017

Design Patent PTO Litigation Statistics (Through July 1, 2017)

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Firm News

May 31, 2017

Sterne Kessler Ranked Among Best IP Firms In The U.S. By The Legal 500

Multiple Authors

Articles

April 28, 2017

Show and Tell: Successful Examiner Interview Strategies for Consumer Product Cases

Sterne, Kessler, Goldstein & Fox Mark W. Rygiel

Books and Chapters

February 17, 2017

Patent Office Litigation – Second Edition 2017

Thomson Reuters Westlaw Multiple Authors

In the News

June 20, 2016

Apple Scores PTAB Victory, Nixes Claims In DSS Tech. Patent

Law360 Multiple Authors

In the News

November 20, 2015

PTAB Keeps Magna’s Windshield Camera Patent Intact

Law360 Multiple Authors

In the News

March 27, 2015

Apple Gets Claims Cut From PersonalWeb’s Data Patent

Law360 Multiple Authors

In the News

November 17, 2014

Apple Pushes PTAB To Nix PersonalWeb’s Data Patent Claims

Law360 Multiple Authors

Client Alert

September 2, 2014

Utility Patent Trends Gleaned from the IPO’s 2014 IP Record

Mark W. Rygiel

In the News

July 22, 2014

First Patent Derivation Decisions by PTO Use Established Standards to Deny Petitions

BNA Daily Report for Executives Multiple Authors

Client Alert

April 23, 2014

PTAB Invalidates Patent in First IPR Trial of a Design Patent

Mark W. Rygiel, Tracy-Gene G. Durkin

Articles

January 31, 2014

Consumer Product IP: Coffee Isn’t the Only Cure for Exhaustion

IP Today Daniel A. Gajewski, Mark W. Rygiel